In This Section

CICR Steering Committee

Joachim Rudolph, PhD
Chair

Joachim Rudolph, PhD

(2021-2022)

Principal Scientist, Discovery Chemistry
Genentech, Inc.
South San Francisco, California

Mary M. Mader, PhD
Chair-Elect

Mary M. Mader, PhD

(2021-2022)

Vice President, Chemistry
Relay Therapeutics
Cambridge, Massachusetts

Philip Jones, PhD
Past Chair

Philip Jones, PhD

(2021-2022)

Vice President, Therapeutics Discovery, and Head of Drug Discovery
UT MD Anderson Cancer Center
Houston, Texas

James E. Audia, PhD

James E. Audia, PhD

(2019-2022)

Visiting Scholar, Northwestern University
Head of Medicinal Chemistry and Senior Advisor, Karuna Therapeutics
Entrepreneur-in Residence, Third Rock Ventures
Evanston, Illlinois

Laura D’Agostino, PhD

Laura D’Agostino, PhD

(2020-2023)

Director
Bristol Myers Squibb
Cambridge, Massachusetts

Ivan Cornella-Taracido, PhD

Ivan Cornella-Taracido, PhD

(2019-2022)

Vice President, Proteomics and Chemical Biology
Cedilla Therapeutics
Cambridge, Massachusetts

Adrian L. Gill, PhD

Adrian L. Gill, PhD

(2020-2023)

Vice President, Medicinal Chemistry
Revolution Medicines
Redwood City, California

Christopher Nasveschuk, PhD

Christopher Nasveschuk, PhD

(2020-2023)

Vice President, Chemistry
C4 Therapeutics
Watertown, Massachusetts

Chudi O. Ndubaku, PhD

Chudi O. Ndubaku, PhD

(2019-2022)

Vice President, Drug Discovery
ORIC Pharmaceuticals
South San Francisco, California

Xiaojing (Gina) Wang, PhD

Xiaojing (Gina) Wang, PhD

(2019-2022)

Principal Scientist and Project Team Lead
Genentech, Inc.
South San Francisco, California